Erlotinib versus carboplatin/vinorelbine in elderly patients (age 70 or older) with advanced non-small cell lung carcinoma (NSCLC): A randomized phase II study of the German Thoracic Oncology Working Group

Autor: Reck, M., Von Pawel, J., Fischer, J. R., Kortsik, C., Bohnet, S., von Eiff, M., Koester, W., Thomas, M., Schnabel, P., Deppermann, K. M., German Thoracic Oncology Working Group
Rok vydání: 2010
Předmět:
Zdroj: Journal of Clinical Oncology. 28:7565-7565
ISSN: 1527-7755
0732-183X
DOI: 10.1200/jco.2010.28.15_suppl.7565
Popis: 7565 Background: Treatment of elderly patients remains a challenge. We compared the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) erlotinib which has shown promising resul...
Databáze: OpenAIRE
Pro tento záznam nejsou dostupné žádné jednotky.